Viewing Study NCT05086666


Ignite Creation Date: 2025-12-24 @ 4:08 PM
Ignite Modification Date: 2026-02-03 @ 3:27 AM
Study NCT ID: NCT05086666
Status: UNKNOWN
Last Update Posted: 2021-10-21
First Post: 2021-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1b/2 Clinical Study to Evaluate the Safety and Tolerability and Efficacy of AZD4547
Sponsor: Abbisko Therapeutics Co, Ltd
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-06-03
Start Date Type: ACTUAL
Primary Completion Date: 2023-08-14
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-05-27
Completion Date Type: ESTIMATED
First Submit Date: 2021-10-09
First Submit QC Date: None
Study First Post Date: 2021-10-21
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-10-20
Last Update Post Date: 2021-10-21
Last Update Post Date Type: ACTUAL